Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5401_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •1.1 Introduction
- •1.2 The Evolution of Herbal Medicine: A Historical Perspective
- •1.3 Diversity of Herbal Pharmacopoeias Across the Globe
- •1.3.1 The Indian Pharmacopoeia (IP)
- •1.3.2 The European Pharmacopoeia (Ph. Eur.)
- •1.3.3 United States Pharmacopoeia (USP)
- •1.3.4 The Russian Federation’s State Pharmacopoeia (SPRF)
- •1.3.6 Hausa Herbal Pharmacopoeia
- •1.5 Ayurveda and the Integration of Nanotechnology
- •1.6 Enhancing Herbal Medicines Through Nanotechnology
- •1.7 Approaches of Nanotechnology in Herbal Medicine
- •1.7.1 Solid Lipid Nanoparticles (SLN)
- •1.7.2 Nanoemulsions
- •1.7.3 Liposomes
- •1.7.4 Ethosomes, Transferosomes, and Transethosomes
- •1.7.5 Niosomes and Phytosomes
- •1.7.6 Micelles, Dendrimers, and Nanostructured Lipid Carriers (NLCs)
- •1.7.7 Nanoparticles, Nanocapsules, and Nanogels
- •1.8 Types of Novel Drug Delivery Systems (NDDS)
- •1.9 Nanotechnology and Its Applications
- •1.10 Efficacy and Safety of Herbal Medicine
- •1.11 Concept of Bhasma and Nanotechnology
- •1.11.1 Nanoparticle Nature of Bhasma
- •1.3.5 Romanian Pharmacopoeia (RPh)
- •1.12 Supermolecules and Nanotechnology
- •1.14 Future Prospects of Nanomedicines
- •1.15 Conclusion
- •References
- •2.1 Introduction
- •2.2 Prehistory
- •2.2.1 Ancient Civilization
- •2.2.1.1 Mesopotamia
- •2.2.1.2 Ancient Egypt
- •2.2.1.3 India, China, Greece, & Rome
- •2.2.1.3.1 India
- •2.2.1.3.2 China
- •2.2.1.3.3 Greece and Rome
- •2.3 Middle Ages and Beyond
- •2.3.1 Translation of Herbals
- •2.3.2 Early Modern Era
- •2.4 Modern Times
- •2.5 Current Status
- •2.6 Challenges Associated
- •2.6.1 Regulation and Safety of Herbal Medications
- •2.6.2 Quality Control of Herbal Medicine
- •2.6.3 Safety Monitoring of Herbal Medicines
- •2.6.4 Bioavailability of Herbal Medicines
- •2.6.5 Clinical Trials
- •2.7 Future Perspectives
- •2.8 Conclusion
- •References
- •3.1 Introduction
- •3.2 Herbal Extraction
- •3.2.2 Choice: Solvent Selection of a Suitable Medium
- •3.3 Supercritical Fluid Extraction (SFE)
- •3.3.1 Working Principle of SFE
- •3.3.2 Parts of the SFE System
- •3.3.3 Process of extraction
- •3.3.4 Applications
- •3.4 Microwave-Assisted Extraction (MAE)
- •3.4.1 Working Principle
- •3.4.2 Components of a Microwave-Assisted Extraction System
- •3.4.3 Method of Extraction from Herbs by MAE
- •3.5 Ultrasound-Assisted Extraction (UAE)
- •3.5.1 Working Principle
- •3.9.3 Applications of GC-MS in Herbal Analysis
- •3.9.4 Endowed Oil Analysis
- •3.9.5 Alkaloids and Phenolic Compounds
- •3.9.6 Terpenoids
- •3.9.7 Quantitative Analysis
- •3.9.8 Data Analysis and Interpretation
- •3.10 Liquid Chromatography-Mass Spectrometry (LC-MS)
- •3.10.1 Principles of Liquid Chromatography-Mass Spectrometry
- •3.5.1.1 Cell Disruption
- •3.5.1.2 Increased Mass Transport
- •3.5.1.3 Enhanced Solvent Effectiveness
- •3.5.2 Parts of the Ultrasound-Assisted Extraction System
- •3.5.3 Method of Extraction from Herbs
- •3.6 Pressurized Liquid Extraction (PLE)
- •3.6.1 Definition
- •3.6.2 Working Principle
- •3.6.3 Parts of the PLE System
- •3.6.4 PLE Extraction Method
- •3.7 Subcritical Water Extraction (SWE)
- •3.7.1 Supercritical fluids
- •3.7.2 Supercritical Fluid Extraction (SFE)
- •3.7.3 Working Principle of Subcritical Water Extraction (SWE)
- •3.7.4 Parts of the Subcritical Water Extraction System
- •3.7.5 Process of Subcritical Water Extraction
- •3.8 High-Performance Liquid Chromatography (HPLC)
- •3.8.1 Principles of HPLC
- •3.8.2 Bioactive Compounds Analysis
- •3.8.2.1 Phenolic Compounds
- •3.8.2.2 Alkaloids
- •3.8.2.3 Terpenoids
- •3.8.3 Recent Advances in HPLC Techniques
- •3.8.3.1 Ultra-High-Performance Liquid Chromatography
- •3.8.3.2 HPLC-MS
- •3.8.3.3 Chiral HPLC
- •3.8.4 Applications of Herbal Medicine
- •3.8.4.1 Quality Control
- •3.8.4.2 Pharmacokinetic
- •3.8.4.3 Challenges and Prospects for Further Study
- •3.9 Gas Chromatography-Mass Spectrometry (GC-MS)
- •3.9.1 Principles of GC-MS
- •3.9.2 Sample Preparation
- •3.10.2 Methods for LC-MS Detection Analysis
- •3.10.2.1 Applications of LC-MS in Herbal Analysis
- •3.10.3 Principles of FTIR
- •3.10.4 Application of FTIR in Herb Analysis
- •3.10.5 Phytochemical Identification
- •3.10.6 Quantitation of Bioactive Compounds
- •3.10.7 Structural Elucidation
- •3.10.8 Sample Preparation for FTIR Analysis
- •3.10.9 Direct Analysis
- •3.10.10 Extraction
- •3.10.11 Pellet Preparation
- •3.10.12 Thin Films
- •3.10.13 Data Analysis and Interpretation
- •3.10.14 Advantages of FTIR on Herb Analysis
- •3.10.15 Non-Destructive
- •3.10.16 Fast and Easy
- •3.10.17 Rich Information
- •3.10.18 Versatility
- •3.10.19 Cost-Effective
- •3.10.20 FTIR Limitations and Low Sensitivity
- •3.10.21 Overlapping Bands
- •3.10.22 Preparation of the Sample
- •3.10.23 Conclusion
- •3.11 Nuclear Magnetic Resonance Spectroscopy (NMR)
- •3.11.1 Sample Preparation and Instrumentation
- •3.11.2 One-Dimensional NMR Spectroscopy
- •3.11.3 Two-Dimensional NMR Spectroscopy
- •3.11.4 Phytochemical Applications
- •3.11.6 Techniques of Standardization
- •3.11.7 Extraction and Analysis of Bioactive Compounds
- •3.11.8 Conclusion
- •References
- •4.1 Introduction
- •4.2 Historical Context of Plant-Based Medicines
- •4.2.2 Development of Pharmacognosy
- •4.2.3 Impact of Plant-Based Medicines on Modern Pharmacology
- •4.3.1 Integration of Ethnobotanical Knowledge
- •4.3.2 Advanced Phytochemical Techniques
- •4.3.3 Bioassay-Guided Fractionation
- •4.3.4 Role of Metabolomics and Genomics
- •4.3.5 Integration of Nanotechnology
- •4.4 Ethnobotanical Approaches
- •4.4.1 Traditional Knowledge and Indigenous Applications
- •4.4.2 Ethnopharmacological Surveys and Their Relevance
- •4.5 Phytochemical Techniques
- •4.5.1 Methods of Plant Extraction and Isolation
- •4.5.1.1 Solvent Extraction
- •4.5.1.2 Supercritical Fluid Extraction (SFE)
- •4.5.1.3 Microwave-Assisted Extraction (MAE)
- •4.5.1.4 Ultrasound-Assisted Extraction (UAE)
- •4.5.1.5 Enzyme-Assisted Extraction (EAE)
- •4.6 Bioassay-Guided Fractionation
- •4.6.1 Fractionation Techniques
- •4.6.2 Biological Assays
- •4.6.3 Iterative Purification
- •4.7.1 High-Performance Liquid Chromatography (HPLC)
- •4.7.2 Gas Chromatography-Mass Spectrometry (GC-MS)
- •4.7.3 Nuclear Magnetic Resonance (NMR) Spectroscopy
- •4.7.4 Fourier Transform Infrared (FTIR) Spectroscopy
- •4.7.5 Metabolomics and Genomics in Plant Drug Discovery
- •4.8 Role of Metabolomics in Identifying Bioactive Compounds
- •4.8.1 Identification of Bioactive Compounds
- •4.8.2 Explanation of Biosynthetic Pathways
- •4.8.3 Discovery of Biosynthetic Genes
- •4.8.4 Enhancement of Phytochemical Production
- •4.9 Case Studies of Genomic Applications in Drug Discovery
- •4.9.1 Case Study 1: Artemisinin Production in Artemisia annua
- •4.9.2 Case Study 2: Taxol Biosynthesis in Taxus spp.
- •4.9.3 Case Study 3: Resveratrol Production in Vitis vinifera
- •4.10 Biotechnological Advances
- •4.10.1 Tissue Culture and the Genetic Modification of Medicinal Plants
- •4.10.2 Sustainable Production of Phytochemicals through Biotechnology
- •4.10.3 Role of Synthetic Biology in Plant-Based Drug Development
- •4.11 Nanotechnology in Phytochemical Delivery
- •4.11.1 Enhancing the Bioavailability of Plant-Derived Drugs with Nanocarriers
- •4.11.1.1 Nanoparticles
- •4.11.1.2 Liposomes
- •4.11.1.3 Nanoemulsions
- •4.11.2 Targeted Delivery Systems Using Nanotechnology
- •4.11.2.1 Active Targeting
- •4.11.2.2 Passive Targeting
- •4.11.2.3 Multifunctional Nanocarriers
- •4.11.3 Case Studies of Nano-Formulated Phytochemicals
- •4.11.3.1 Curcumin-Loaded Nanoparticles
- •4.11.3.2 Quercetin-Loaded Liposomes
- •4.11.3.3 Resveratrol-Functionalized Gold Nanoparticles
- •4.11.3.4 Nanoemulsion Formulations of Essential Oils
- •4.12.1 Paclitaxel (Taxol)
- •4.12.2 Artemisinin
- •4.12.3 Morphine
- •4.12.4 Quinine
- •4.12.5 Challenges and Limitations in Plant-Based Drug Development
- •4.12.5.1 Complexity of Plant Extracts
- •4.12.5.2 Variability in Chemical Composition
- •4.12.5.3 Sustainable Sourcing and Conservation
- •4.12.5.4 Regulatory and Approval Processes
- •4.12.6 Intellectual Property and Benefit Sharing
- •4.13 Future Perspectives
- •4.13.1 Emerging Trends in Plant-Based Drug Discovery
- •4.13.2 Integrating Traditional Knowledge with Modern Science
- •4.13.3 Potential of Plant Genomics and Biotechnology
- •4.14 Conclusion
- •References
- •5.1 Introduction
- •5.2 Traditional Phytomedicine
- •5.3 Modern Phytomedicine
- •5.4 Synthesis and Purpose of Bioactive Compounds
- •5.5.1 Phenolic Compounds (PCs)
- •5.5.2 Terpenes
- •5.5.3 Nitrogen-Containing Compounds
- •5.6 Extraction of Bioactive Compounds
- •5.7 Role of Herbs in Drug Discovery
- •5.8 Global Trade of Herbal Medicines
- •5.9.1 Herbal Compounds for the Human Immune System
- •5.9.2 Bioactive Compounds in Herbs For Cancer Treatment
- •5.9.3 Bioactive Compounds for Neurodegenerative Diseases
- •5.9.4 Bioactive Compounds for Viral Diseases
- •5.9.5 Anti-Inflammatory Bioactive Compounds in Herbs
- •5.9.6 Antidiabetic Bioactive Compounds in Herbs
- •5.9.7 Antibiotics
- •5.10 Summary
- •References
- •6.1 Introduction
- •6.1.2 Antibiotic-Resistant Microorganisms
- •6.1.3 Necessity of Developing Natural Plant-Derived Drugs
- •6.2 Pharmacological Activities of Medicinal Plants
- •6.2.1 Antimicrobial Activity of Herbal Drugs
- •6.2.2 Anticancer Activity of Medicinal Herbs
- •6.2.3 Antiviral Activity of Medicinal Herbs
- •6.2.3.1 Medicinal Plants Exhibiting Antiviral Activity
- •6.2.4 Antioxidant Activity of Medicinal Herbs
- •6.2.5 Hepatoprotective Activity of Medicinal Herbs
- •6.2.6 Nervous System Activity of Medicinal Herbs
- •6.2.7 Anti-Inflammatory Activity of Medicinal Herbs
- •6.2.7.1 Mechanism of Action
- •6.2.8 Antipyretic Activity of Medicinal Herbs
- •6.2.8.1 Medicinal Plants Possessing Antipyretic Properties
- •6.2.9 Antiallergic Activity of Medicinal Herbs
- •6.2.10 Antidiabetic Activity of Medicinal Herbs
- •6.2.10.1 Medicinal Plants Possessing Antidiabetic Activity
- •6.2.11 Immunomodulatory Activity of Medicinal Herbs
- •6.3 Advantages of Medicinal Herbs
- •6.4 Disadvantages of Medicinal Herbs
- •6.5 Future Prospects of Medicinal Herbs
- •References
- •7.1 Introduction to Herbal Drug Discovery
- •7.1.1 History of Herbal Drug Discovery
- •7.2 Current trends in herbal drug discovery
- •7.2.1 Molecular and Genetic Study Levels
- •7.2.2 Molecular Pharmacognosy
- •7.2.3 Combination Therapy
- •7.2.4 Conservation and Propagation Strategies
- •7.2.5 Pharmacogenomics
- •7.2.6 Computational Resources for Drug Discovery
- •7.4.1 Metabolomics Approaches in Herbal Drug Discovery
- •7.4.2 Genomic Approaches
- •7.5.1 Quinine for Malarial Treatment
- •7.5.2 Aspirin for Pain and the Treatment of Inflammation
- •7.6 Limitations in Herbal Drug Discovery
- •7.6.1 Regulatory Hurdles
- •7.6.2 Emerging Technologies
- •References
- •8.1 Introduction
- •8.2 Traditional Approaches to Herbal Formulation
- •8.3 Phytochemical Constituents in Herbal Formulations
- •8.3.1 Alkaloids
- •8.3.2 Flavonoids
- •8.3.3 Terpenoids
- •8.3.4 Glycosides
- •8.3.5 Tannins
- •8.3.6 Phenolic Acids
- •8.3.7 Saponins
- •8.4 Modern Extraction Techniques in Herbal Formulation
- •8.4.1 Solvent Extraction
- •8.4.2 Supercritical Fluid Extraction (SFE)
- •8.4.3 Ultrasonic Extraction
- •8.4.4 Microwave-Assisted Extraction (MAE)
- •8.4.5 Enzyme-Assisted Extraction (EAE)
- •8.4.6 Comparative Analysis of Extraction Techniques
- •8.5 Advanced Formulation Strategies
- •8.5.1 Nanotechnology in Herbal Formulations
- •8.5.1.1 Nanoemulsions
- •8.5.1.2 Liposomes
- •8.5.1.3 Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs)
- •8.5.2 Encapsulation Techniques
- •8.5.2.1 Microencapsulation
- •8.5.2.2 Coacervation
- •8.5.2.3 Spray Drying
- •8.5.3 Standardized Extracts
- •8.5.3.1 Methods of Standardization
- •8.5.3.2 Challenges in Standardization
- •8.5.4 Synergistic Formulations
- •8.5.4.1 Mechanisms of Synergy
- •8.5.4.2 Examples of Synergistic Formulations
- •8.5.5 Personalized Herbal Formulations
- •8.5.5.1 Role of Genomics in Personalized Herbal Medicine
- •8.5.5.2 Challenges in Personalized Herbal Formulations
- •8.6.1 Recognition and Verification of Herbal Materials
- •8.6.1.4 DNA Barcoding
- •8.6.2 Use of Reference Standards
- •8.6.2.1 Primary and Secondary Reference Standards
- •8.6.2.2 Development of Reference Standards
- •8.6.3 Good Manufacturing Practices (GMP)
- •8.6.3.1 Sourcing and Handling of Raw Materials
- •8.6.3.2 Manufacturing Processes
- •8.6.3.3 Quality Control Testing
- •8.6.3.4 Documentation and Record-Keeping
- •8.7 Challenges in Herbal Formulation Development
- •8.7.1 Variability in Chemical Composition
- •8.7.1.1 Factors Affecting Chemical Composition
- •8.7.1.2 Strategies to Address Variability
- •8.7.2 Complexity of Herbal Extracts
- •8.7.2.1 Analytical Challenges
- •8.7.2.2 Formulation Challenges
- •8.7.3 Standardization of Herbal Formulations
- •8.7.3.1 Challenges in Standardization
- •8.7.3.2 Advances in Standardization
- •8.7.4 Regulatory Hurdles
- •8.7.4.1 Regulatory Requirements
- •8.7.4.2 Challenges in Meeting Regulatory Requirements
- •8.7.4.3 Strategies to Overcome Regulatory Hurdles
- •8.8 Future Directions in Herbal Formulation Development
- •8.8.1 Artificial Intelligence and Machine Learning
- •8.8.1.1 Applications in Herbal Formulation Development
- •8.8.1.2 Challenges and Opportunities
- •8.8.2 Integration of Omics Technologies
- •8.8.2.1 Applications in Herbal Medicine
- •8.8.2.2 Challenges and Opportunities
- •8.8.3 Novel Delivery Systems
- •8.8.3.1 Nanotechnology in Herbal Medicine
- •8.8.3.2 Other Novel Delivery Systems
- •8.8.3.3 Challenges and Opportunities
- •8.9 Conclusion
- •References
- •9.1 Introduction
- •9.2 Herbal Nanotechnology and Phytonanomedicines
- •9.2.1 Role of Phytonanomedicines in Disease Management
- •9.2.1.1 Cancer
- •9.2.1.2 Diabetes Mellitus
- •9.2.1.3 Neurodegenerative Diseases (NDDs)
- •9.2.1.4 Cardiovascular Diseases (CVD)
- •9.3 Nanoparticles for Plant Disease Management
- •9.3.1 Role of Silver Nanoparticles (AgNPs) in Plant Disease Management
- •9.3.2 Role of Gold Nanoparticles (AuNPs) in Plant Disease Management
- •9.3.3 Role of Zinc Nanoparticles (ZnNPs) in Plant Disease Management
- •9.3.4 Role of Palladium Nanoparticles (PdNPs) in Plant Disease Management
- •9.3.5 Role of Titanium Nanoparticles (TiNPs) in Plant Disease Management
- •9.3.6 Role of Iron Nanoparticles (FeNPs) in Plant Disease Management
- •9.3.7 Role of Copper Nanoparticles (CuNPs) in Plant Disease Management
- •9.3.8 Role of Selenium Nanoparticles (SeNPs) in Plant Disease Management
- •9.4 Nanoparticles as Carriers
- •9.4.1 Nanoparticles as Carriers for Insecticides
- •9.4.2 Nanoparticles as Carriers for Fungicides
- •9.4.3 Nanoparticles as Carriers for Herbicides
- •9.4.4 Role of Nanoparticles and RNAi in Plant Disease Management
- •References
- •10.1 Introduction
- •10.2 Types of Nanomaterials Utilized in Herbal Pharmaceuticals
- •10.2.1 Nanoparticles
- •10.2.2 Nanocapsules
- •10.2.3 Nanospheres
- •10.2.4 Nanotubes
- •10.3 Innovative Applications of Nanotechnology
- •10.3.1 Anti-Cancer Herbal Nanomedicine
- •10.3.2 Anti-Inflammatory Herbal Nanomedicine
- •10.3.3 Antibacterial Herbal Nanomedicine
- •10.3.4 Antifungal Herbal Nanomedicine
- •10.3.5 Antioxidant Neuroprotective Herbal Nanomedicine
- •10.3.6 Anti-Diabetic Herbal Nanomedicine
- •10.3.7 Cardioprotective Herbal Nanomedicine
- •10.4.1 Combining Nanotechnology and Herbal Pharmacotherapy
- •10.4.2 Enhanced Bioavailability
- •10.4.3 Targeted Delivery
- •10.4.4 Improved Stability or Shelf Life
- •10.4.5 Synergistic Effects and Combination Therapies
- •10.4.6 Reduced Dosage and Toxicity
- •10.4.7 Crossing Biological Barriers
- •10.5 Challenges and Limitations
- •10.5.1 Complexity of Herbal Systems
- •10.5.2 Bioavailability Enhancement
- •10.5.3 Regulatory and Ethical Considerations
- •10.5.4 Cost and Scalability
- •10.5.5 Safety and Toxicity Issues
- •10.5.6 Standardization and Quality Control
- •10.6 Future Prospects and Trends
- •10.7 Conclusion
- •References
- •11. Nanoparticle Synthesis and Characterization for Herbal Drug Delivery
- •11.1 Introductions
- •11.2 Background and Literature Review
- •11.2.1 Historical Overview and Present Trends in Herbal Medicine
- •11.2.2 Overview of Nanoparticles in Drug Delivery
- •11.2.3 Advantages of Nanoparticle-Based Drug Delivery Systems
- •11.3.1 Polymer Nanoparticle
- •11.3.2 Metallic Nanoparticles
- •11.3.3 Magnetic Nanoparticles
- •11.3.4 Liposomes
- •11.3.5 Dendrimers
- •11.3.6 Niosomes
- •11.3.7 Proniosomes
- •11.3.8 Phytosomes
- •11.3.9 Transfersomes
- •11.3.10 Microspheres
- •11.3.11 Ethosomes
- •11.4 Nanoparticle Synthesis Techniques
- •11.4.1 Top-Down Approach
- •11.4.2 Bottom-Up Approach
- •11.4.3 Chemical Methods
- •11.4.3.1 Sol-Gel Method
- •11.4.3.2 Spinning
- •11.4.3.3 Microemulsion Technique
- •11.4.3.4 Hydrothermal Synthesis
- •11.4.3.5 Electrochemical Synthesis
- •11.4.3.6 Polyol Synthesis
- •11.4.3.7 Thermal Decomposition
- •11.4.3.8 Chemical Vapor Deposition & Chemical Vapor Synthesis
- •11.4.3.9 Plasma-Enhanced Chemical Vapor Deposition
- •11.4.4 Physical Methods
- •11.4.4.1 High-Energy Ball Milling Process
- •11.4.4.2 Physical Vapor Deposition (PVD)
- •11.4.4.3 Pyrolysis
- •11.4.4.4 Melt Mixing
- •11.4.4.5 Laser Ablation (LA) and Pulse Laser Deposition (PLD)
- •11.4.4.6 Electron Beam Evaporation (EBE)
- •11.4.4.7 Inert Gas Condensation (IGC)
- •11.4.4.8 Flame Spray Pyrolysis (FSP)
- •11.4.4.9 Laser Pyrolysis
- •11.4.4.10 Nanolithography
- •11.4.4.11 Electrospraying Technique
- •11.4.5 Biosynthesis of Nanoparticles
- •11.4.5.1 Utilizing Biomolecules as Templates for Synthesis
- •11.4.5.2 Microbial Synthesis
- •11.4.5.3 Utilizing Botanical Extracts for Synthesis
- •11.4.6 Mechanical Techniques
- •11.5 Characterization of Nanoparticles
- •11.5.1 Chemical
- •11.5.2 Physical
- •11.5.2.1 Particle Size Analyzer
- •11.5.2.2 Surface Area Analysis
- •11.5.2.3 Zeta Potential
- •11.5.2.4 Thermogravimetric Analysis (TGA)
- •11.5.2.5 Dynamic Light Scattering
- •11.5.2.6 Scanning Electron Microscopy (SEM)
- •11.5.2.7 Nuclear Magnetic Resonance
- •11.5.2.8 Transmission Electron Microscopy (TEM)
- •11.5.2.9 X-Ray Powder Diffraction (XRD)
- •11.5.2.10 Evaluation of Recovery and Encapsulation Performance
- •11.5.2.11 Atomic Force Microscopy
- •11.5.2.12 UV-Visble Spectroscopy
- •11.5.2.13 Surface Plasmon Resonance
- •11.5.2.14 Acoustic Methods
- •11.6 Conclusion
- •References
- •12.1 Introduction
- •12.1.1 Challenges of Herbal Extracts in Traditional Medicine
- •12.1.2 Importance of Bioavailability in Therapeutic Efficacy
- •12.1.3 The Role of Nanotechnology in Addressing Bioavailability Issues
- •12.2 Principles of Bioavailability Enhancement
- •12.2.1 Understanding ADME Profiles
- •12.2.1.1 Absorption
- •12.2.1.1.1 Distribution
- •12.2.1.1.2 Metabolism
- •12.2.1.1.3 Excretion
- •12.2.2 Factors Affecting the Bioavailability of Herbal Compounds
- •12.2.2.1 Absorption within the GI Lumen
- •12.2.2.1.1 The Solubility of the Herbal Products
- •12.2.2.1.2 Absorption via Passive Diffusion
- •12.2.2.2 Metabolism
- •12.2.2.2.1 Metabolism Prior to Absorption
- •12.2.2.2.2 Metabolism Post-Absorption
- •12.2.2.3 Mechanisms of Action for Nanocarriers
- •12.3 Types of Nanocarriers and Their Applications
- •12.3.1 Liposomes: Structure, Function, and Applications
- •12.3.1.1 Structure
- •12.3.1.2 Function
- •12.3.1.3 Applications
- •12.3.2 Polymeric Nanoparticles: Design and Delivery Mechanisms
- •12.3.2.1 Design
- •12.3.2.1.1 Polymeric Material
- •12.3.2.1.2 Drug Encapsulation Methods
- •12.3.2.1.2.1 Solvent Evaporation
- •12.3.2.2 The Delivery Mechanism of the Drug
- •12.3.2.2.1 Route of Delivery
- •12.3.2.2.2 Targeting Strategies
- •12.3.2.2.2.1 Passive Targeting
- •12.3.2.2.2.2 Active Targeting
- •12.3.2.2.2.3 Stimuli-Responsive Targeting
- •12.3.2.2.3 Drug Release
- •12.3.2.2.3.1 Diffusion-Controlled Release
- •12.3.2.2.3.2 Solvent-Controlled Release
- •12.3.2.2.3.3 Chemical Interaction-Based Release
- •12.3.2.2.3.4 Temperature-Controlled Release
- •12.3.3 Nanoemulsions: Formulation and Stability
- •12.3.3.1 Formulation
- •12.3.3.1.1 The Generation of Nanoemulsion
- •12.3.3.2 Stability
- •12.3.3.2.1 Physical Stability
- •12.3.3.2.2 Chemical Stability
- •12.3.4 Micelles: Enhancing Solubility and Bioavailability
- •12.3.4.1 Enhancing Solubility and Bioavailability
- •12.3.4.1.1 Micellar Solubilization
- •12.3.4.1.2 Polymeric Micellar Nanocarriers
- •12.4 Nanocarriers and Solubility Enhancement
- •12.4.1 Techniques for Improving the Solubility of Hydrophobic Compounds
- •12.4.1.1 Lipid Dispersion Techniques
- •12.5 Stability of Herbal Extracts in Nanocarrier Systems
- •12.5.1 Protection against Degradation and Oxidation
- •12.5.2 Example of Stability Improvement in Herbal Extracts
- •12.5.2.2 Example 2: Enhancing Curcumin Stability and Bioavailability using SLNs
- •12.6 Targeted Delivery and Controlled Release
- •12.6.1 Key Principles
- •12.6.1.2 Design and Composition of Nanocarriers
- •12.6.1.2.1 Integration and Optimization
- •12.6.1.2.2 Advantages of Controlled Release Systems
- •12.6.1.2.3 Applications in Medicine
- •12.7 Pharmacokinetics and Pharmacodynamics
- •12.7.1 Enhancing Therapeutic Efficacy through Pharmacokinetic Modulation
- •12.7.1.1 Sustained Release and Targeted Delivery
- •12.7.1.2 Improved Bioavailability and Reduced Inter-Individual Variability
- •12.7.1.3 Enhanced Pharmacodynamic Effects
- •12.7.1.4 Reduced Adverse Effects and Toxicity
- •12.7.1.5 Opportunities for Personalized Medicine
- •12.7.2 Clinical Implications of Improved Pharmacodynamics
- •12.8 Clinical Applications and Case Studies
- •12.8.1 Successful Implementations of Nanocarrier-Based Herbal Drugs
- •12.8.1.1 Curcumin-Loaded Nanoparticles
- •12.8.1.2 Quercetin-Loaded Liposomes
- •12.8.1.3 Ginger Extract Nanocarriers
- •12.8.1.4 Green Tea Extract Nanocarriers
- •12.8.2 Challenges and Limitations in Clinical Settings
- •12.8.2.1 Quality Control and Standardization
- •12.8.2.2 Limited Encapsulation Capacity
- •12.8.2.3 Pharmacokinetic and Pharmacodynamic Variability
- •12.8.2.4 Manufacturing Challenges
- •12.9 Future Perspectives
- •12.9.1 Advancing Nanocarrier Design and Engineering
- •12.9.2 Expanding the Diversity of Herbal Extracts Formulated with Nanocarriers
- •12.9.3 Advancing Preclinical and Clinical Evaluation
- •12.9.4 Addressing Regulatory and Commercialization Challenges
- •12.9.5 Exploring Synergies with Other Emerging Technologies
- •12.10.1 Opportunities
- •12.10.2 Challenges
- •12.11 Conclusion
- •References
- •13.1 Introduction to Herbal Medicine and Neurological Diseases
- •13.1.1 Overview of Herbal Medicine
- •13.1.1.1 Key Aspects of Herbal Medicine
- •13.1.2 Scope of Neurological Diseases
- •13.1.3 Rationale for Exploring Herbal Remedies
- •13.2 Neuroprotective Effects of Herbal Compounds
- •13.2.1 Mechanisms of Neuroprotection
- •13.2.1.1 Antioxidant Activity
- •13.2.1.3 Inhibition of Excitotoxicity
- •13.2.1.4 Enhancement of Neurogenesis and Synaptic Plasticity
- •13.2.1.5 Mitochondrial Protection
- •13.2.2 Role of Oxidative Stress in Neurological Diseases
- •13.2.2.1 Essential Components of Oxidative Stress in Neurological Disorders
- •13.2.2.1.1 Impaired Functioning of Mitochondria
- •13.2.2.1.2 Neurological Disorders Linked to Oxidative Stress
- •13.2.3 Anti-Inflammatory Properties of Herbal Compounds
- •13.2.3.2 Uses and Advantages
- •13.2.4 Regulation of Neuronal Apoptosis by Herbal Remedies
- •13.2.4.1 Neurological Diseases Applications
- •13.2.4.2 Future Scope and Challenges of Therapy
- •13.3.1 Importance of Neurogenesis in Brain Repair
- •13.3.2 Effects of Herbal Extracts on Neurogenesis
- •13.3.3 Enhancement of Synaptic Plasticity by Herbal Compounds
- •13.4 Herbal Medicine as Adjunctive Therapy
- •13.4.1 Synergistic Effects of Herbal Compounds with Conventional Treatments
- •13.4.1.1 Cancer Care
- •13.4.1.2 Depression Relief
- •13.4.1.3 Heart Health
- •13.4.1.4 Diabetes Management
- •13.4.1.5 Pain Relief
- •13.4.2 Mitigation of Drug-Induced Side Effects
- •13.4.2.1 Digestive Challenges
- •13.4.2.2 Liver Safeguarding
- •13.4.2.3 Kidney Protection
- •13.4.2.4 Neurotoxicity
- •13.4.2.5 Cardiotoxicity
- •13.4.2.6 Bone Marrow Suppression
- •13.4.2.7 Managing Fatigue
- •13.4.3 Enhancement of Therapeutic Outcomes
- •13.5 Future Directions and Challenges
- •13.5.1 Opportunities for Further Research
- •13.5.2 Challenges in Herbal Medicine Research
- •13.5.3 Integration of Traditional Knowledge with Modern Science
- •13.6 Case Studies and Clinical Applications
- •13.6.1 Illustrative Case Studies
- •13.6.2 Clinical Applications of Herbal Medicine in Neurological Diseases
- •13.7 Conclusion
- •13.7.1 Summary of Key Findings
- •13.7.2 Future Outlook for Herbal Medicine in Neurology
- •References
- •14.1 Introduction
- •14.1.2.1 Physiochemical Characteristics and Biological Interactions
- •14.1.2.2 Potential Toxicity Concerns
- •14.1.2.3 Regulatory and Ethical Considerations
- •14.2 Preclinical Safety Assessment
- •14.2.1 In vitro Toxicity Testing
- •14.2.2 In vivo Animal Studies
- •14.2.3 Evaluating the Pharmacokinetics and Biodistribution of Nanoparticles
- •14.2.4 Immunogenicity and Biocompatibility Testing
- •14.3 Toxicological Profiling
- •14.3.1 Identification and Characterization of Possible Toxins
- •14.3.1.1 Nanoparticle Components
- •14.3.1.2 Contaminants and Impurities
- •14.3.1.3 Herbal Compounds
- •14.3.2 Dose–Response Relationships
- •14.4 Chronic Toxicity and Carcinogenicity Studies
- •14.4.1 Genotoxicity and Mutagenicity Testing
- •14.5 Clinical Safety Assessment
- •14.5.1 Phases of Clinical Trials for Nanoparticle-Based Herbal Formulation
- •14.5.2 Monitoring Adverse Effects and Long-Term Safety in Human Subjects
- •14.5.2.1 Initial Reporting Systems
- •14.5.2.2 Clinical Monitoring
- •14.5.2.3 Pharmacovigilance Networks
- •14.5.2.4 Regular Safety Updates
- •14.5.2.5 Post-Marketing Studies
- •14.5.2.6 Pharmacogenomics Studies
- •14.5.3 Post-Market Surveillance and Pharmacovigilance
- •14.5.3.1 Real-World Evidence Collection
- •14.5.3.2 Active Surveillance Programs
- •14.5.3.3 Signal Detection
- •14.5.3.4 Risk Communication
- •14.5.3.5 Regulatory Actions
- •14.6 Analytical Techniques for Safety Assessment
- •14.6.1 Advanced Imaging and Spectroscopy Methods
- •14.6.1.1 Transmission Electron Microscopy (TEM)
- •14.6.1.2 Scanning Electron Microscopy (SEM)
- •14.6.1.3 Infrared Spectroscopy (IRS)
- •14.6.2 Nanoparticle Tracking and Quantification
- •14.6.2.1 Nanoparticle Tracking Analysis (NTA)
- •14.6.2.2 Dynamic Light Scattering (DLS)
- •14.6.3 Surface Characterization and Stability Analysis
- •14.6.3.1 X-Ray Photoelectron Spectroscopy (XPS)
- •14.6.3.2 Differential Scanning Calorimetry (DSC)
- •14.6.4 High-Throughput Screening Technologies
- •14.6.4.1 Cell-Based Assay
- •14.6.4.2 Genotoxicity Screening
- •14.7 Regulatory Frameworks and Guidelines
- •14.7.1 International and National Regulatory Frameworks
- •14.7.1.1 Regulation Management
- •14.7.1.2 Risk Analysis
- •14.7.1.3 Labelling and Informed Consent
- •14.7.1.4 International Standards
- •14.7.1.5 Regulation in Research and Development
- •14.7.2 Risk Assessment Models and Safety Thresholds
- •14.7.2.1 Invitro Toxicity Assay
- •14.7.2.2 Green Algorithms
- •14.7.2.3 Nanoprobes for Measuring ROS
- •14.8 Risk Mitigation Strategies
- •14.8.1 Designing Safer Nanoparticle-Based Formulations
- •14.8.2 Controlled Release Systems and Targeted Delivery
- •14.8.3 Reducing Off-Target Effects and Enhancing Selectivity
- •14.8.3.1 Nanoparticle-Based Systems for Intracellular Targeting
- •14.8.4 Engineering Biodegradable and Biocompatible Nanoparticles
- •14.9 Case Studies of Safety Assessment
- •14.9.1 Successful Examples of Safe Nanoparticle-based Herbal Formulations
- •14.9.1.1 Curcumin-Loaded Nanoparticles
- •14.9.1.2 Green Tea Polyphenol (EGCG) Nanoparticles
- •14.9.2 Lessons Learned from Safety Failures and Recalls
- •14.10 Ethical Considerations
- •14.10.1 Ethical Issues in Nanotoxicology Research
- •14.10.2 Informed Consent and Patient Safety in Clinical Trials
- •14.11 Conclusion
- •References
- •15. Novel Drug Delivery Methods for Herbal Medicine
- •15.1 Introduction
- •15.2 Novel Drug Delivery Approaches
- •15.3 Potential of Novel Drug Delivery for Herbal Drugs
- •15.4 Types of Novel Herbal Drug Delivery Systems
- •15.4.1 Mouth-Dissolving Tablets
- •15.4.2 Controlled-Release Formulations
- •15.4.3 Liposomes
- •15.4.4 Phytosomes
- •15.4.5 Nanoparticles
- •15.4.6 Niosomes
- •15.4.7 Proniosomes
- •15.4.8 Transdermal Drug Delivery System
- •15.4.9 Microspheres
- •15.4.10 Emulsions
- •15.4.11 Ethosomes
- •15.4.12 Other Novel Approaches
- •15.5 Future Opportunities and Challenges
- •15.6 Conclusion
- •References
- •16.1 Fundamentals of Herbal Drug Delivery Systems
- •16.1.1 Advantages of Herbal Drugs
- •16.1.2 Challenges of Herbal Drugs
- •16.1.3 Rise of Targeted Delivery for Herbal Drugs
- •16.2 Carriers Systems for Targeted Drugs
- •16.2.1 Liposome-Mediated Drug Delivery System
- •16.2.2 Polymeric Nanoparticles as Drug Carriers
- •16.2.3 Micelles
- •16.2.4 Dendrimers
- •16.2.5 Carbon Nanotubes and Fullerenes
- •16.2.6 Phytosomes
- •16.2.7 DNA Nanocarriers for Targeted Drug Delivery
- •16.2.8 Aptamers for Drug Targeting
- •16.2.9 Microspheres and Micropellets
- •16.3 Targeting Strategies and Mechanisms
- •16.3.1 Ligand-Receptor Mediated Targeting
- •16.3.2 Antibody Drug Conjugates
- •16.3.3 Aptamers for a Targeted Delivery System for Herbal Drugs
- •16.3.4 Stimuli-Responsive Delivery Systems
- •16.4.1 Herbal Drugs for Communicable Diseases
- •16.4.2 Herbal Drugs for Communicable and Non-Communicable Diseases
- •16.5 Conclusion and Future Perspective
- •References
- •17.1 Introduction
- •17.2 An Overview of Phytomedicine
- •17.3 Application of Nanoformulation
- •17.3.1 Nanosuspension Technology
- •17.3.2 Nano-Encapsulation
- •17.3.3 Three-Dimensional Printing in Nanopharmacy (Nano Printing)
- •17.3.4 Applications in Drug Delivery Systems
- •17.3.5 Biomimetics and Bioinspiration in Nanopharmaceuticals/Nanomedicines
- •17.3.6 Green Design
- •17.4 Future study
- •17.5 Conclusion
- •References
- •18.1 Introduction
- •18.2 Herbal Phytoconstituents for Disease Management
- •18.3 Barriers to Herbal Formulations
- •18.4 Strategies to Enhance Bioavailability
- •18.5 Herbal Formulations – Conventional Dosage Forms
- •18.6 Nanocarriers in Herbal Drug Delivery
- •18.7 Clinical Status of Current Delivery Strategies
- •18.8 Conclusion
- •References
- •19.1 Introduction
- •19.1.1 Definition and Scope
- •19.1.2 History
- •19.1.3 Importance and Relevance in Modern Medicine
- •19.2 Basics of Nanotechnology and Herbal Medicines
- •19.2.1 Nanotechnology
- •19.2.2 Basics of Herbal Medicines
- •19.3 Implementing Herbal Nanomedicines
- •19.3.1 Protocols for Implementation
- •19.3.1.1 Techniques for the Preparation of Herbal Nanoparticles
- •19.3.1.2 Dosage and Administration Strategies
- •19.3.2 Documenting Patient Case Histories and its Analysis
- •19.3.2.1.1 Condition Treated
- •19.3.2.1.2 Treatment Provided
- •19.3.2.1.3 Patient Response
- •19.4 Standardized Treatment Procedures
- •19.4.1 Customization for Specific Ailments
- •19.4.2 Tailoring for Individual Patient Needs
- •19.5 Advantages of Herbal Nanomedicine in Clinical Settings
- •19.5.1 Increased Patient Adherence
- •19.5.2 Reduced Side Effects
- •19.5.3 Improved Efficacy
- •19.6 The Future of Herbal Nanomedicine in Clinical Practice
- •References
- •20.1 Herbal Nanomedicines: A Brief Overview
- •20.2 Safety Issues and Toxicological Concerns with Herbal Nanomedicines
- •20.3.1 In Vitro Methods
- •20.3.2 In Vivo Assays
- •20.3.3 Utilization of Advanced Analytical Tools
- •20.3.4 In Silico Approach: Nano-QSAR
- •20.3.5 Grouping/Read-Across Technique
- •20.3.6 Genetic Approaches
- •20.3.7 Utilization of Validated Human Cell Lines in Immunotoxicity Assays
- •20.3.8 In Vitro Carcinogenicity Assessment with Transformed Cells
- •20.3.9 DNA Barcoding
- •20.3.10 Systems Toxicology: ‘Omics’ Technology
- •20.3.11 Nano-Informatics Database
- •20.3.12 Miscellaneous Advanced Approaches in Nanotoxicology Assessment
- •20.7 Conclusion
- •Acknowledgement
- •References
- •21.1 Introduction
- •21.2 Global Regulatory Landscape
- •21.3 Regulatory Agencies and Their Roles
- •21.3.1 United States
- •21.3.1.1 Key Responsibilities of the FDA
- •21.3.2 Canada
- •21.3.3 Europe
- •21.3.3.1 European Medicine Agency
- •21.3.3.2 Key Responsibilities of the European Medicine Agency
- •21.3.3.3 Quality Guidelines of the European Medicine Agency
- •21.3.3.3.1 The Declaration of Herbal Preparations in Traditional Herbal Medicinal Products
- •21.3.3.3.2 Practices for Materials Collection from Herbal Origin
- •21.3.4 Non-Clinical Guidelines
- •21.3.4.1 Genotoxicity Assessment of Herbal Preparations
- •21.3.5 Asia
- •21.3.5.1 Traditional Chinese Medicines
- •21.3.5.2 Regulatory Approaches for TM/CM
- •21.3.6 Indian Ayurvedic Regulations
- •21.3.6.1 Food Safety and Standards Authority of India
- •21.3.7 World Health Organization
- •21.3.7.1 WHO Guidelines on the Safety Monitoring of Herbal Medicines
- •21.4 Classification of Herbal Products
- •21.4.1 Dietary Supplements
- •21.4.2 Herbal Supplements
- •21.4.3 Functional Food
- •21.4.4 Traditional Medicine
- •21.5 Approval Process
- •21.5.1 Pre-Market Approval
- •21.5.2 Post-Market Surveillance
- •21.5.3 Clinical Trials
- •21.6 Diverse Regulatory Standards
- •21.6.1 Example of Divergence
- •21.7 Efforts for International Collaboration
- •21.8 Impact of Scientific Advancements
- •21.8.1 Combination of Modern Research and Traditional Knowledge
- •21.8.2 Recognizing the Value of Traditional Knowledge
- •21.9 Approaches to Integration
- •21.9.1 Collaborative Research
- •21.9.2 Participatory Research
- •21.9.3 Interdisciplinary Research
- •21.9.4 Comparative Research
- •21.10 Challenges & Considerations
- •21.11 Advanced Technologies in Quality Control
- •21.11.1 Analytical Techniques
- •21.11.2 Good Manufacturing Practices (GMP)
- •21.11.3 Biological Assays
- •21.11.4 Standardization of Extraction Methods
- •21.11.5 Data Management & Traceability
- •21.12 Challenges & Future Directions
- •21.13 Personalized Herbal Medicine
- •21.14 Regulatory Implications
- •21.15 Sustainable and Ethical Sourcing
- •21.16 Conclusion
- •21.17 Future Outlook for the Regulatory Framework
- •References
- •22. Present Challenges and Future Perspective of the Herbal Drug Industry
- •22.1 Introduction
- •22.2 Emerging Trends and Innovations
- •22.2.1 Biotechnology and Genetic Engineering
- •22.2.2 Nanotechnology
- •22.3 Regulatory Challenges and Opportunities
- •22.4 Intellectual Property Rights
- •22.4.1 Conventional Medicine and Rights to Intellectual Property
- •22.5 Global Market Trends
- •22.6 Challenges and Limitations
- •22.7 Future Directions
- •22.8 Conclusions
- •References
- •Index

164 Herbal Pharmacopeia
98. Alonso, A., Marsal, S., Julià, A. Analytical methods in untargeted metabolomics: State of the art in 2015.
Front Bioeng Biotechnol 2015;3(MAR):23.
99. Zhang, A., Sun, H., Wang, P., Han, Y., & Wang, X. Modern analytical techniques in metabolomics analy-
sis. Analyst. 2012. [cited 2024 Jul 19]; Available from: https://pubs.rsc.org/en/content/articlehtml/2012/
an/c1an15605e
100. Ziemert, N., Alanjary, M., & Weber, T. The evolution of genome mining in microbes–a review. Nat.
Prod. Rep.. 2016. [cited 2024 Jul 19]; Available from: https://pubs.rsc.org/en/content/articlehtml/2016/
np/c6np00025h
101. Trivella, D. B., & de Felicio, R. The tripod for bacterial natural product discovery: genome mining, silent
pathway induction, and mass spectrometry- based molecular networking. System. 2018 Apr 24 [cited
2024 Jul 19];3(2). Available from: https://journals.asm.org/doi/abs/10.1128/msystems.00160-17
102. Helfrich, E. J., Reiter, S., & Piel, J. Recent advances in genome- based polyketide discovery. Curr. Opin.
Biotechnol.. 2014. [cited 2024 Jul 19]; Available from: https://www.sciencedirect.com/science/article/
pii/S0958166914000676
103. Olano, C., Méndez, C., & Salas, J.A. Molecular insights on the biosynthesis of antitumour compounds
by actinomycetes. Microb. Biotechnol. 2011 Mar;4(2):144–64.
104. Nett, M., Ikeda, H., & Moore, B. S. Genomic basis for natural product biosynthetic diversity in the acti-
nomycetes. Nat. Prod. Rep.. 2009. [cited 2024 Jul 19]; Available from: https://pubs.rsc.org/en/content/
articlehtml/2009/np/b817069j
105. Olano, C., Méndez, C, & Salas, J.A. Strategies for the design and discovery of novel antibiotics using genetic
engineering and genome mining. Antimicrobial Compounds: Current Strategies and New Alternatives.
2013 Dec 1;1–25.
106. Machado, H., Tuttle, R. N., & Jensen, P. R. Omics- based natural product discovery and the lexicon
of genome mining. Curr. Opin. Microbiol.. 2017. [cited 2024 Jul 19]; Available from: https://www.
sciencedirect.com/science/article/pii/S136952741730108X
107. Haldar, S., & Mody, K.H. Genome mining for bioactive compounds. Springer Handbook of Marine
Biotechnology. 2015 Jan 1;531–9.
108. Packard, R.M. The Making of a Tropical Disease: A… - Google Scholar. [cited 2024 Jul 19]. Available from:
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Packard%2C+ R.M.+The+ Making+
of+ a+ Tropical+ Disease%3A+ A+ Short+ History+ of+ Malaria%3B+ JHU+ Press%3A+ Baltimore%2C+
MD%2C+ USA%2C+ 2021%3B+ Available+ online%3A+ &btnG=
109. Capasso, F. Phytotherapy: a quick reference to herbal medicine. 2003 [cited 2024 Jul 19]. Available from:
https://books.google.com/books?hl=en&lr=&id=ejHpcJXzPTsC&oi=fnd&pg=PA1&dq=Capasso,+F.+
Phytotherapy:+A+ Quick+ Reference+ to+ Herbal+ Medicine%3B+ Springer+ Science+ %26+Business+
Media:+Berlin/Heidelberg,+Germany,+2003%3B+ Available+ online:+&ots=sWfdgrXe8j&sig=XL0j9t
x3mH0szOZAixn_HGjt7xY
110. Dagen, M. History of malaria and its treatment. Antimalarial agents. Elsevier. 2020. [cited 2024 Jul 19];
Available from: https://www.sciencedirect.com/science/article/pii/B9780081012109000019
111. Rogers, K. Out of Nature: Why Drugs from Plants Matter to the Future of Humanity. 2012 [cited 2024
Jul 19]. Available from: https://books.google.com/books?hl=en&lr=&id=HTbUdjdUBy8C&oi=fnd&
pg=PR5&dq=+Rogers,+K.+Out+ of+ Nature:+Why+ Drugs+ from+ Plants+ Matter+ to+ the+ Future+
of+ Humanity%3B+ University+ of+ Arizona+ Press:+Tucson,+AZ,+USA,+2012%3B+ Available+ online:
+&ots=4t766LDZWL&sig=5243GQFTtnY5VXvWLYw2-W1SOmI
112. David, B., Wolfender, J.L., & Dias, D.A. The pharmaceutical industry and natural products: historical
status and new trends. Phytochem. Rev. 2015 Apr 1;14(2):299–315.
113. Ugurlucan, M., Caglar, I.M., Turhan Caglar, F.N., Ziyade, S., Karatepe, O., Yildiz, Y., et al. Aspirin:
from a historical perspective. Recent Pat. Cardiovasc. Drug Discov.. 2012 [cited 2024 Jul 19];7:71–6.
Available from: https://www.ingentaconnect.com/content/ben/prc/2012/00000007/00000001/art00009
114. Levesque, H., & Lafont, O. Aspirin throughout the ages: a historical review. Rev. Médecine Interne..
[cited 2024 Jul 19]; Available from: https://europepmc.org/article/med/10763200
115. El Hajj, M., & Holst, L. Herbal medicine use during pregnancy: A review of the literature with a special
focus on Sub- Saharan Africa. Front. Pharmacol. 2020 Jun 9;11.
116. Indrayanto, G., Putra, G.S., & Suhud, F. Validation of in- vitro bioassay methods: Application in herbal
drug research. Proles Drug Subst. Excip. Relat. Methodol. 2021 Jan 1;46:273–307.
117. Nunavath, R.S., & Nagappan, K. Identication of synthetic impurities and their signicance in natural
products quality control. Nat. Prod. Commun. 2024 May 1;19(5).

Biotechnological Approaches for Herbal Drug Discovery 165
118. Li, C., Jia, W. W., Yang, J. L., Cheng, C., & Olaleye, O. E.. Multi- compound and drug- combination phar-
macokinetic research on Chinese herbal medicines. Acta Pharmacol. Sin.. 2022 Dec 1 [cited 2024 Jul
19];43(12):3080–95. Available from: https://www.nature.com/articles/s41401-022-00983-7
119. Steenkamp, V., Parkar, H., & Dasgupta, A. Utility of therapeutic drug monitoring in identifying clinically
signicant interactions between St. John’s Wort and Prescription Drugs. Ther. Drug Monit. 2023 Feb
1;45(1):35–44.
120. Jayram, J., Kondaveeti, S.S., Gnanaraj Johnson, C., Sampath, P.J., Kalachaveedu, M. Challenges and
prospects of development of herbal biomaterial based ethical wound care products — A scoping review.
Int J Low Extrem Wounds 2024 Jun 1;23(2):291–305.
121. Adeoye, I., & Etuk, V. Prevalence, predictors and pregnancy outcomes of unprescribed and herbal med-
icine use in Ibadan, Nigeria. BMC Complement. Med. Ther.. 2023 Dec 1 [cited 2024 Jul 19];23(1).
Available from: https://link.springer.com/article/10.1186/s12906-023-03838-8
122. Ko, J.M. Advancing orphan drug development for rare diseases. Clin Exp Pediatr. 2023 Jul 15;67:356
123. Dubey, R. K., & Shukla, S. Exploring Novel Herbal Compounds and Formulations for Inammatory
Bowel Disease (IBD) Management. Chin. J. Appl. Physiol.. 2023 Dec 16 [cited 2024 Jul 19];39:2023–35.
Available from: http://47.94.85.12:8889/resources/uploads/20240508/1715153350607052306.pdf
124. Sezer, F., Deniz, S., Sevim, D., Chaachouay, N., & Zidane, L. Plant- derived natural products: a source
for drug discovery and development. Drugs Drug Candidates. 2024 Feb 19 [cited 2024 Jul 18];3(1):184–
207. Available from: https://www.mdpi.com/2813-2998/3/1/11
125. Larrosa, C., Mora, J., Cheung, N.K. Global Impact of Monoclonal Antibodies (mAbs) in children: A
focus on Anti- GD2. Cancers (Basel) 2023 Jul 1;15(14).
126. van Hunsel, F. P., van der Kooi, D., van de Koppel, S., Kroes, B. H., & Woerdenbag, H. J. Analysis of
reports on adverse drug reactions related to herbal medicinal products and herbal supplements in the
Netherlands received by the national. Drug Saf.. 2022 Jun 1 [cited 2024 Jul 19];45(6):651–61. Available
from: https://link.springer.com/article/10.1007/s40264-022-01180-5
127. Niazi, S., & Pharmaceuticals, Z.M. Computer- aided drug design and drug discovery: a prospec-
tive analysis. Pharmaceuticals, [cited 2024 Jul 19];17(1):22. Available from: https://www.mdpi.com/
1424-8247/17/1/22
128. Yao, R., Heinrich, M., Zhang, B., Wei, X., Qi, Y., & Gao, W. Single botanical drugs in the Ayurvedic
Pharmacopoeia of India—A quantitative ethnobotanical analysis. Front. Pharmacol. 2023;14:1136446.
129. Lin, C., Tian, Q., Guo, S., Xie, D., Cai, Y., Wang, Z., et al. Metabolomics for clinical biomarker discovery
and therapeutic target identication. Molecules 2024 May 1;29(10):2198.
130. Kumar, S., Urumarudappa, J., Tungphatthong, C., Jaipaew, J., Pornputtapong, N., Pakdeesattayapong,
D., et al. Development of a DNA barcode library of plants in the Thai Herbal Pharmacopoeia and
Monographs for authentication of herbal products. Sci. Rep., [cited 2024 Jul 19];12(1). Available from:
https://www.nature.com/articles/s41598-022-13287-x
131. Liu, C., Yu, H., Chen, G., Yang, Q., Wang, Z., Niu, N., et al. An herbal drug combination identied by
knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: A nonrandomized
controlled trial. elife, [cited 2024 Jul 19]; Available from: https://elifesciences.org/articles/84414
132. Komolafe, K., Komolafe, T.R., Fatoki, T.H., Akinmoladun, A.C., Brai, B.I.C., Olaleye, M.T., et al.
Coronavirus Disease 2019 and Herbal Therapy: Pertinent Issues Relating to Toxicity and Standardization
of Phytopharmaceuticals. Rev. Bras 2021 Apr 1;31(2):142–61.
133. Eruaga, M.A., Itua, E.O., & Bature, J.T. The role of regulatory authorities in the regulation and control
of herbal medicines: A case study of NAFDAC. Int. J. Sci. Res. Arch.. 2024 Mar 30 [cited 2024 Jul
19];2024(02):207–11. Available from: https://ijsra.net/content/role- regulatory- authorities- regulation- and-
control- herbal- medicines- case- study- nafdac
134. Bhat, M.D.A., & Malik, R. Challenges in monitoring the safety of herbal medicines- an appraisal.
J.Pharmacovigil. Drug Res. 2022 Dec 1;3(4):3–8.

Herbal Formulation
8
Development and
Standardization
Rabiya Rashid
Ayush Medical ofcer, Community health Centre Sankoo Kargil,
Ladakh, India
Sanjeev Kumar, Ab Waheed Wani, and Anis Ahmad Mirza
Department of Horticulture, School of agriculture, Lovely Professional
University, Phagwara, India
Bilal Ah Bhat and Zarina
Ayush Medical ofcer, Primary health Centre Shargole, Kargil,
Ladakh, India
8.1 INTRODUCTION
Herbal medicine has been an integral part of human healthcare for thousands of years, with its
roots in various conventional practices like traditional Chinese medicine (TCM) and Ayurveda,
and Indigenous knowledge systems across the globe. These systems have established the framework for the creation of herbal formulations, which are used to treat a wide array of health conditions. The past few years have seen a resurgence in the popularity of herbal products, driven by
the global shift towards natural and holistic approaches to health and wellness. The increasing
demand for herbal products, coupled with the advancements in scientic research, has brought the
development and standardization of herbal formulations to the forefront of modern pharmaceutical practices (Patel etal., 2022).
Despite the rich history and widespread use of herbal medicine, the development and standardization of herbal formulations pose signicant challenges. These challenges stem from the inherent
variability in the chemical composition of medicinal plants, which is affected by elements like geographic location, climate, cultivation practices, and harvesting techniques. Additionally, the lack of
standardized protocols for the extraction, formulation, and quality control of herbal products has led
to inconsistencies in their therapeutic efcacy and safety. This has underscored the need for rigorous
standardization processes that ensure the consistency, safety, and efcacy of herbal formulations
(Singh et al., 2021).
Standardization of herbal formulations involves the establishment of consistent manufacturing
processes, including the use of standardized extracts with well- dened chemical proles, the
implementation of quality control measures throughout the production process, and the adherence
to regulatory guidelines. This chapter delves into the various aspects of herbal formulation
166

Herbal Formulation Development and Standardization 167
development, from traditional approaches to modern extraction techniques, and explores the critical role of standardization in guaranteeing the effectiveness and quality of herbal products.
Through a series of case studies and discussions on current challenges and future directions, this
chapter seeks to offer a thorough summary of the strategies employed in the standardization of
herbal formulations.
8.2 TRADITIONAL APPROACHES TO HERBAL FORMULATION
Herbal medicine has been practiced for millennia, with each traditional system developing its own
methods for formulating herbal remedies. These traditional approaches to herbal formulation are
deeply rooted in the cultural and historical context of the societies that developed them. For instance,
one of the oldest medical systems, Ayurveda, dates back more than 5,000 years to India and is
predicated on the balancing of the three doshas: Pitta, Kapha, and Vata. Ayurvedic formulations
often consist of multiple herbs, combined in specic proportions to achieve a synergistic effect that
balances these doshas and restores health (Mukherjee et al., 2015).
In traditional Chinese medicine (TCM), herbal formulations are also a cornerstone of treatment,
with over 13,000 medicinal herbs and more than 100,000 recipes documented in ancient texts. TCM
formulations are based on the principles of Yin and Yang, and the Five Elements, which govern the
balance and harmony within the body. Herbal combinations are meticulously crafted to address the
underlying causes of disease by harmonizing the body's internal environment. Commonly used
TCM herbs include ginseng (Panax ginseng), astragalus (Astragalus membranaceus), and licorice
(Glycyrrhiza glabra), each selected for its unique properties and its role within the larger formulation (Wang et al., 2019).
While these traditional approaches have provided effective treatments for centuries, they are
often based on empirical knowledge and lack the rigorous scientic validation required by modern
pharmaceutical standards. The challenge lies in translating this traditional knowledge into standardized formulations that meet contemporary expectations for safety, efcacy, and quality. This requires
a deep understanding of the pharmacological properties of individual herbs, as well as the interactions between them within a formulation.
8.3 PHYTOCHEMICAL CONSTITUENTS IN HERBAL FORMULATIONS
Phytochemicals are naturally occurring compounds found in plants which are essential to their
medicinal properties. These bioactive compounds are the cornerstone of many herbal formulations,
contributing to their therapeutic effects. Understanding the types of phytochemicals present in herbs
and their biological activities is essential for the development and standardization of herbal formulations. This section delves into the common phytochemical groups, their specic examples, biological activities, and sources, as outlined in Table 8.1 and Figure 8.1.
8.3.1 AlkAloids
Alkaloids are a broad class of nitrogen- containing substances with strong biological effects.
Examples include morphine, quinine, and berberine. Morphine, derived from the poppy plant
(Papaver somniferum), is widely recognized for its analgesic properties, making it one of the most
effective pain relievers available. Quinine, extracted from Cinchona species, has been used for cen-
turies as an antimalarial agent. Finally, berberine, found in Berberis species, exhibits antimicrobial
properties, making it useful in treating infections (Heinrich et al., 2009).

168 Herbal Pharmacopeia
TABLE 8.1
Phytochemical Constituents Commonly Found in Herbal Formulations
Phytochemical
Group Examples Biological Activity Common Sources References
Alkaloids Morphine, Quinine,
Berberine
Flavonoids Quercetin,
Kaempferol,
Rutin
Terpenoids Menthol, Limonene,
Carotenoids
Glycosides Digoxin, Salicin,
Saponins
Tannins Ellagic acid, Tannic
acid
Phenolic acids Caffeic acid, Gallic
acid
Saponins Dioscin,
Ginsenosides
Analgesic, antimalarial,
antimicrobial
Antioxidant, anti-
inammatory,
cardioprotective
Anti- inammatory,
antimicrobial, antioxidant
Cardiotonic, anti-
inammatory, expectorant
Astringent, antimicrobial,
antioxidant
Antioxidant, anti-
inammatory,
antimicrobial
Antioxidant,
immunomodulatory,
anti- inammatory
Poppy (Papaver
somniferum),
Cinchona, Berberis
Citrus fruits, onions, tea Mukherjee et al., 2012;
Mint (Mentha), Citrus
peels, Carrots
Foxglove (Digitalis),
Willow bark, Soapwort
Oak (Quercus),
Pomegranate, Tea
Berries, Coffee, Spices Li et al., 2008;
Ginseng, Soybeans,
Yucca
Heinrich et al., 2009;
Gibson et al., 2019
Li et al., 2008
Verpoorte et al., 2005;
Sarker & Nahar, 2012
Heinrich et al., 2009;
Bent, 2008
Sarker & Nahar, 2012;
Patra et al., 2018
Mahapatra et al.,
2021
Ekor, 2013; Heinrich
etal., 2009
FIGURE 8.1 Commonly occurring phytochemical components in herbal formulations.

Herbal Formulation Development and Standardization 169
These alkaloids are often the active ingredients in traditional herbal remedies and are critical in
modern pharmacology due to their efcacy in treating various conditions. However, their potent
effects also necessitate careful standardization and dosage control to avoid toxicity (Gibson et al.,
2019).
8.3.2 FlAvonoids
Flavonoids, such as quercetin, kaempferol, and rutin, are widely dispersed polyphenolic chemicals found in the kingdom of plants. These compounds are renowned for their antioxidant properties, which aid in the body's defence against oxidative stress and the neutralization of free radicals.
Quercetin, found in onions and apples, also exhibits anti- inammatory and cardioprotective effects.
Kaempferol and rutin, present in various fruits and vegetables, contribute to vascular health by
strengthening capillaries and reducing inammation (Mukherjee et al., 2012).
The inclusion of avonoid- rich herbs in formulations is common due to their broad spectrum of
health benets. Their role in preventing chronic diseases, such as cardiovascular diseases and cancer, highlights the importance of maintaining high levels of these compounds in herbal products
through proper extraction and formulation techniques (Li et al., 2008).
8.3.3 Terpenoids
Terpenoids, including menthol, limonene, and carotenoids, are another signicant group of phytochemicals. Menthol, derived from mint species (Mentha), is renowned for providing a cooling
feeling and is widely used in products for respiratory relief. Limonene, found in citrus peels, has
anti- inammatory and antimicrobial properties, while carotenoids, like beta- carotene, are potent
antioxidants that contribute to skin health and immune function (Verpoorte et al., 2005).
Terpenoids are often incorporated into formulations for their medicinal qualities, such as antioxidant, antibacterial, and anti- inammatory capabilities. Their natural aroma and avor also enhance
the sensory appeal of herbal products (Sarker & Nahar, 2012).
8.3.4 Glycosides
A sugar molecule linked to a non- carbohydrate component is called a glycoside. Notable examples
include digoxin, salicin, and saponins. Digoxin, extracted from Digitalis species (foxglove), is an
effective cardiotonic medication used to treat arrhythmias and heart failure. Salicin, found in willow
bark, serves as a precursor to aspirin and has analgesic and anti- inammatory properties. Saponins,
present in soapwort and ginseng, exhibit expectorant and immune- boosting activities (Heinrich
etal., 2009).
The presence of glycosides in herbal formulations contributes to their efcacy in treating cardiovascular, inammatory, and respiratory conditions. Standardizing these compounds is crucial to
ensure consistency and safety in herbal remedies (Bent, 2008).
8.3.5 TAnnins
Tannins, like tannic and ellagic acids, are astringent compounds that precipitate proteins and other
organic compounds. These phytochemicals are commonly found in oak (Quercus), pomegranate,
and tea. Tannins possess antimicrobial and antioxidant properties, making them useful in wound
healing, gastrointestinal disorders, and as natural preservatives (Sarker & Nahar, 2012).
Their astringent action is particularly benecial in formulations intended for treating diarrhoea,
bleeding, and other conditions requiring tissue tightening and protection. The standardization of tannin
content is vital to avoid excessive astringency, which can lead to adverse effects (Patra et al., 2018).

170 Herbal Pharmacopeia
8.3.6 phenolic Acids
Gallic acid and caffeic acid are examples of phenolic acids, which are secondary metabolites with
strong anti- inammatory and antioxidant characteristics. These substances are abundant in berries,
coffee, and spices. Free radical scavenging is the well- known property of gallic acid, whereas the
anti- inammatory and antibacterial properties of caffeic acid (Li et al., 2008).
Herbal formulations containing phenolic acids are often targeted at reducing oxidative stress and
inammation, which are underlying factors in many chronic diseases. Ensuring an adequate concentration of these compounds in the nal product is essential for achieving the desired therapeutic
outcomes (Mahapatra et al., 2021).
8.3.7 sAponins
Saponins, including dioscin and ginsenosides, are glycosides with soap- like properties. They are
found in plants like ginseng and soybeans. Saponins have immunomodulatory and anti- inammatory
activities, making them valuable in formulations aimed at boosting immune function and reducing
inammation. The special qualities of saponins, namely their capacity to create emulsions and stable
foams, are also leveraged in the formulation of topical and oral products. The standardization of
saponin content is necessary to balance their therapeutic benets with potential irritant effects (Ekor,
2013; Heinrich et al., 2009).
8.4 MODERN EXTRACTION TECHNIQUES IN HERBAL FORMULATION
The development of herbal formulations has greatly beneted from advancements in extraction
techniques, which make it possible to separate bioactive substances from plant materials in a targeted manner. These modern extraction methods have been instrumental in enhancing the potency
and consistency of herbal products, while also enabling the production of standardized extracts with
well- dened chemical proles. Some of the most commonly used extraction techniques in herbal
formulation include solvent extraction, enzyme- assisted extraction (EAE), microwave- assisted
extraction (MAE), ultrasonic extraction, and supercritical uid extraction (SFE) (Figure 8.2).
8.4.1 solvenT exTrAcTion
Solvent extraction is one of the most traditional and often- utilized techniques for extracting bioactive compounds from medicinal plants. Using solvents like water, ethanol, or methanol, the targeted
chemicals are dissolved from the plant matrix using this approach. The content of the nal extract
and the effectiveness of the extraction process are both inuenced by the choice of solvent. For
instance, polar chemicals like avonoids and glycosides are often extracted using water, whereas
less polar compounds like terpenoids and alkaloids are best extracted using ethanol and methanol
(Dhanani et al., 2017).
Solvent extraction is a valuable technique that may be applied to both large- scale industrial production and small- scale laboratory investigations due to its scalability and simplicity. However, this
method also has limitations, including the potential for solvent residues in the nal product, the
degradation of thermolabile compounds during the extraction process, and the extraction of
unwanted impurities. To overcome these challenges, researchers have developed optimized extraction protocols that involve the careful selection of solvents, extraction temperatures, and extraction
times to maximize the yield and purity of the desired compounds (Li et al., 2020).
For instance, the extraction of curcumin from turmeric (Curcuma longa) typically involves the
use of ethanol or acetone as solvents, followed by purication steps to isolate curcumin from other
curcuminoids and impurities. The resulting standardized extract, containing a high concentration of
curcumin, is widely used in herbal formulations for its anti- inammatory and antioxidant properties
(Aggarwal et al., 2013).

Herbal Formulation Development and Standardization 171
FIGURE 8.2 Contemporary methods of extraction in herbal formulation.
8.4.2 supercriTicAl Fluid exTrAcTion (sFe)
Supercritical uid extraction (SFE) is a modern technique that uses supercritical uids, typically
using carbon dioxide (CO2) to remove bioactive substances from plant matter. In its supercritical
state, CO2 exhibits both liquid- like solvating power and gas- like diffusivity, allowing it to efciently
penetrate the plant matrix and dissolve target compounds. The use of CO2 as a solvent is particularly
advantageous because it is non- toxic, non- ammable, and easily removed from the nal product by
simple depressurization (Khaw et al., 2017).
SFE is especially effective for extracting thermolabile and non- polar substances, such as fatty
acids, carotenoids, and essential oils, which may be degraded or lost during traditional solvent
extraction. Additionally, by modifying the extraction process’ pressure and temperature, SFE
enables the selective extraction of particular chemicals. For instance, it has been demonstrated that
employing SFE to extract the essential oils of lavender (Lavandula angustifolia) results in a greater
concentration of volatile components, such as linalool and linalyl acetate, compared to traditional
hydro distillation methods (Pourmortazavi & Hajimirsadeghi, 2007).
Despite its advantages, SFE is a relatively complex and expensive technique, needing specic
tools and knowledge. Consequently, its main application in the pharmaceutical industry is the
extraction of high- value chemicals, cosmetic, and food industries. However, ongoing research is
focused on improving the cost- effectiveness and scalability of SFE, making it a promising technique
for the production of standardized herbal extracts in the future (Lang & Wai, 2021).
8.4.3 ulTrAsonic exTrAcTion
High- frequency sound waves are used in ultrasonic extraction (sometimes referred to as ultrasonication or sonication) to improve the extraction of bioactive chemicals from plant materials. The extraction solvent experiences cavitation bubbles due to the mechanical vibrations produced by ultrasonic
waves. These bubbles burst violently, breaking down the walls of the plant and allowing intracellular
chemicals to be released into the solvent (Tiwari, 2015).

172 Herbal Pharmacopeia
Compared to conventional procedures, ultrasonic extraction has a number of benets, such as
reduced solvent consumption, increased extraction efciency, and shorter extraction timeframes.
This method works especially well for removing avonoids, polyphenols, and other phenolic chemicals from plant sources. For example, the extraction of catechins and other polyphenols from green
tea (Camellia sinensis) using ultrasonic extraction has been shown to yield higher concentrations of
these compounds compared to conventional solvent extraction methods (Wang et al., 2016).
Moreover, ultrasonic extraction readily expanded for use in industrial production, making it a
practical choice for producing standardized herbal extracts on a big scale. However, the effectiveness of this method is dependent on a number of variables, including the frequency and intensity of
the ultrasonic waves, the nature of the solvent, and the characteristics of the plant material. Therefore,
the careful optimization of these parameters is essential to achieve the desired extraction efciency
and product quality (Zhang et al., 2018).
8.4.4 MicrowAve- AssisTed exTrAcTion (MAe)
Another contemporary method that has gained interest in the extraction of bioactive components
from medicinal plants is microwave- assisted extraction (MAE). In MAE, the plant material and
extraction solvent are heated using microwaves, which causes the plant cell walls to break quickly
and release intracellular chemicals into the solvent. The use of microwaves allows for the selective
heating of the plant material, leading to faster extraction times and higher yields compared to conventional heating methods (Eskilsson & Björklund, 2000).
It works especially well for extracting substances that are thermally stable, such as alkaloids,
terpenoids, and avonoids, which require higher temperatures for efcient extraction. For instance,
phenolic chemicals are extracted from medicinal herbs like sage (Salvia ofcinalis) and rosemary
(Rosmarinus ofcinalis), using MAE has been shown to yield higher concentrations of these compounds compared to traditional solvent extraction methods (Xiao et al., 2015).
One of MAE’s main benets is its capacity to reduce the use of solvents, making it an environmentally friendly extraction technique. Additionally, MAE can be easily integrated into existing production lines, making it a cost- effective option for the extensive manufacturing of herbal extracts. However,
like ultrasonic extraction, the effectiveness of MAE depends on various factors, such as the microwave
power, extraction time, and solvent type. Therefore, careful optimization of these parameters is necessary to achieve the desired extraction efciency and product quality (Routray & Orsat, 2012).
8.4.5 enzyMe- AssisTed exTrAcTion (eAe)
By using particular enzymes to break down plant materials’ cell walls, the process known as
‘enzyme- assisted extraction’ (EAE) makes it easier for bioactive chemicals to be released into
the extraction solvent. In EAE, enzymes like cellulases, pectinases, and proteases are frequently
employed to target certain plant cell wall constituents including cellulose, pectin, and proteins. The
use of enzymes in the extraction process not only improves the yield of target compounds but also
reduces the extraction time and the need for harsh solvents (Rai et al., 2016).
EAE is particularly effective for extracting complex polysaccharides, glycosides, and other macromolecules that are difcult to extract using traditional methods. For example, the extraction of
saponins from ginseng (Panax ginseng) using EAE has been shown to yield higher concentrations
of these compounds in contrast to traditional solvent extraction methods (Zheng et al., 2019).
Enhancing the extraction of bioactive chemicals from plant materials that would otherwise be
challenging to handle is one of the main benets of EAE. Additionally, EAE is a gentle extraction
method that preserves the integrity of thermolabile compounds, making it appropriate for removing
delicate bioactive substances. However, the effectiveness of EAE depends on the selection of appropriate enzymes, as well as the optimization of parameters for the extraction process, including temperature, pH, time, and enzyme concentration (Ibrahim et al., 2018).

Herbal Formulation Development and Standardization 173
TABLE 8.2
Common Techniques for the Extraction of Herbal Compounds
Extraction Technique Description Advantages Disadvantages References
Maceration Plant material is soaked
for a while at room
temperature in a
solution.
Percolation Continuous ow of solvent
through a column
of powdered plant
material.
Soxhlet Extraction Continuous extraction
process using a reux
condenser, where
solvent is repeatedly
vaporized and
condensed.
Supercritical Fluid
Extraction (SFE)
Ultrasound- Assisted
Extraction (UAE)
Uses supercritical uids
(usually CO2) to extract
compounds at moderate
temperatures.
Uses ultrasonic waves
to enhance solvent
penetration and improve
extraction efciency.
Simple, cost-
effective, no
specialized
equipment
needed.
Faster than
maceration,
higher yield.
Efcient extraction
with minimal
solvent use.
High selectivity,
environmentally
friendly,
solvent- free.
Faster extraction,
energy- efcient,
uses less solvent.
Time- consuming, less
efcient extraction.
Requires more solvent,
may extract unwanted
components.
Requires special equipment,
not suitable for
thermolabile compounds.
Expensive equipment, not
suitable for all types of
compounds.
Potential degradation of
sensitive compounds,
requires specialized
equipment.
Verpoorte et al.,
2005
Heinrich et al.,
2009
Sarker & Nahar,
2012
Li et al., 2008
Mukherjee et al.,
2012
8.4.6 coMpArATive AnAlysis oF exTrAcTion Techniques
The selection of an extraction process is contingent upon a number of criteria, such as the target
compounds, the nature of the plant material, and the intended use of the extract. Each of the extraction techniques previously covered has pros and cons of its own. For instance, solvent extraction
is a straightforward and affordable method for removing a variety of bioactive substances from a
mixture; but it could call for the use of organic solvents, which may leave residues in the nished
product. On the other hand, SFE is a very effective and eco- friendly method of extracting non- polar
chemicals, but it needs specic tools and knowledge (Table 8.2).
8.5 ADVANCED FORMULATION STRATEGIES
The development of herbal formulations has evolved signicantly with the integration of advanced
technologies that increase the stability, bioavailability, and therapeutic efcacy of herbal compounds.
These advanced formulation strategies include the use of nanotechnology, encapsulation techniques,
standardized extracts, and synergistic combinations of herbs. In this section, we will explore these
strategies in detail, highlighting their role in conquering the difculties posed by conventional herbal
remedies and their capacity to completely transform the herbal medicine industry.
8.5.1 nAnoTechnoloGy in herbAl ForMulATions
Nanotechnology has emerged as a powerful tool in the formulation of herbal products, offering solutions to some of the key challenges in herbal medicine, such as poor bioavailability, the instability of
active compounds, and variable therapeutic efcacy. By decreasing the size of the particles of herbal
Соседние файлы в папке Библиотека им академика М.И. Перельмана
